CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 70 enrolled
Drug / intervention
hypertonic saline +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02266875
NCT02266875Phase 4Completed
CompareCT.gov

Nebulized Hypertonic Saline for Inpatient Use in Chronic Obstructive Pulmonary Disease

OhioHealth·interventional·Posted Oct 17, 2014·Updated Nov 22, 2017

In Brief

A Phase 4 clinical trial evaluating hypertonic saline and standard saline for Chronic Obstructive Pulmonary Disease. Completed, enrolled 70 participants across 1 site.

Detailed Summary

A comparison of albuterol treatments using hypertonic saline (3%) versus standard saline (0.9%) in patients with admitted patients COPD in regard to Modified Borg Dyspnea scale scores after 4 treatments within 24 hours.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Obstructive Pulmonary Disease
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 17, 2014
Enrollment StartOct 1, 2014
Primary CompletionJan 30, 2017
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 11.7 years ago

Interventions

hypertonic salinedrug

standard salinedrug